Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Lodde

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Annals of the Rheumatic Diseases|August 2, 2006
Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatmentB M Lodde, B J Baum, P P Tak, et al.
Biochemical and Biophysical Research Communications|May 26, 2004
A recombinant adenoviral vector encoding functional vasoactive intestinal peptideB M Lodde, C Delporte, C M Goldsmith, et al.
Rheumatology (Oxford, England)|November 24, 2005
Serum lipid levels in Sjögren's syndromeB M Lodde, V Sankar, M R Kok, et al.
Scandinavian Journal of Rheumatology|October 20, 2005
Adult heart block is associated with disease activity in primary Sjögren's syndromeB M Lodde, V Sankar, M R Kok, et al.
Annals of the Rheumatic Diseases|June 25, 2005
Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndromeB M Lodde, F Mineshiba, J Wang, et al.
Gene Therapy|September 24, 2005
Rapamycin control of transgene expression from a single AAV vector in mouse salivary glandsJ Wang, A Voutetakis, M Papa, et al.
Oral Diseases|September 15, 2011
Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren's syndromeN Roescher, B M Lodde, J L Vosters, et al.
Oral Diseases|October 24, 2006
NOD mouse model for Sjögren's syndrome: lack of longitudinal stabilityB M Lodde, F Mineshiba, M R Kok, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Annals of the Rheumatic Diseases|August 2, 2006
Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatmentB M Lodde, B J Baum, P P Tak, et al.
Biochemical and Biophysical Research Communications|May 26, 2004
A recombinant adenoviral vector encoding functional vasoactive intestinal peptideB M Lodde, C Delporte, C M Goldsmith, et al.
Rheumatology (Oxford, England)|November 24, 2005
Serum lipid levels in Sjögren's syndromeB M Lodde, V Sankar, M R Kok, et al.
Scandinavian Journal of Rheumatology|October 20, 2005
Adult heart block is associated with disease activity in primary Sjögren's syndromeB M Lodde, V Sankar, M R Kok, et al.
Annals of the Rheumatic Diseases|June 25, 2005
Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndromeB M Lodde, F Mineshiba, J Wang, et al.
Gene Therapy|September 24, 2005
Rapamycin control of transgene expression from a single AAV vector in mouse salivary glandsJ Wang, A Voutetakis, M Papa, et al.
Oral Diseases|September 15, 2011
Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren's syndromeN Roescher, B M Lodde, J L Vosters, et al.
Oral Diseases|October 24, 2006
NOD mouse model for Sjögren's syndrome: lack of longitudinal stabilityB M Lodde, F Mineshiba, M R Kok, et al.
Pageof 1